Search research articles
Contact Us
Filters
Showing results (321-330 of 554) with videos related to
Page
of 56
Sort By:
Nature
|
May 25, 2012
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D Bell, Ethan A Winkler, Itender Singh, et al.
The Journal of Clinical Investigation
|
January 19, 2008
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease
Suzanne E Wahrle, Hong Jiang, Maia Parsadanian, et al.
Rapid Communications in Mass Spectrometry : RCM
|
November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry
Tomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
Journal of Alzheimer'S Disease : JAD
|
July 8, 2009
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice
Chuanhai Cao, John R Cirrito, Xiaoyang Lin, et al.
JAMA Neurology
|
September 15, 2015
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
Maartje I Kester, Charlotte E Teunissen, Daniel L Crimmins, et al.
Human Molecular Genetics
|
July 24, 2012
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
Carlos Cruchaga, John S K Kauwe, Petra Nowotny, et al.
Neuron
|
May 12, 2020
SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain Injury
Andrew D Sauerbeck, Mihika Gangolli, Sydney J Reitz, et al.
The Journal of Biological Chemistry
|
May 13, 2005
The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice
John D Fryer, Ronald B Demattos, Lynn M McCormick, et al.
JAMA Neurology
|
January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
John C Morris, Suzanne E Schindler, Lena M McCue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 5, 2018
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
Suzanne E Schindler, Julia D Gray, Brian A Gordon, et al.
Page
of 56
Search research articles
Search
Showing results (321-330 of 554) with videos related to
Sort By:
Page
of 56
Nature
|
May 25, 2012
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D Bell, Ethan A Winkler, Itender Singh, et al.
The Journal of Clinical Investigation
|
January 19, 2008
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease
Suzanne E Wahrle, Hong Jiang, Maia Parsadanian, et al.
Rapid Communications in Mass Spectrometry : RCM
|
November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry
Tomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
Journal of Alzheimer'S Disease : JAD
|
July 8, 2009
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice
Chuanhai Cao, John R Cirrito, Xiaoyang Lin, et al.
JAMA Neurology
|
September 15, 2015
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
Maartje I Kester, Charlotte E Teunissen, Daniel L Crimmins, et al.
Human Molecular Genetics
|
July 24, 2012
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
Carlos Cruchaga, John S K Kauwe, Petra Nowotny, et al.
Neuron
|
May 12, 2020
SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain Injury
Andrew D Sauerbeck, Mihika Gangolli, Sydney J Reitz, et al.
The Journal of Biological Chemistry
|
May 13, 2005
The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice
John D Fryer, Ronald B Demattos, Lynn M McCormick, et al.
JAMA Neurology
|
January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
John C Morris, Suzanne E Schindler, Lena M McCue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 5, 2018
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
Suzanne E Schindler, Julia D Gray, Brian A Gordon, et al.
Page
of 56